Article
From structure to ætiology: a new window on the biology of leucine-rich repeat kinase 2 and Parkinson's disease.
The Biochemical journal - 30 Jul 2021
Herbst Susanne, Lewis Patrick A
Abstract excerpt
Since the discovery of mutations in leucine-rich repeat kinase 2 (LRRK2) as an underlying genetic cause for the development of Parkinson's disease (PD) in 2004 (Neuron 44, 601-607; Neuron 44, 595-600), and subsequent efforts to develop LRRK2 kinase inhibitors as a therapy for Parkinson's (Expert Opin. Ther. Targets 21, 751-753), elucidating the atomic resolution structure of LRRK2 has been a major goal of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
